78 Results for "

antidiabetic agent

" in MedChemExpress (MCE) Product Catalog:
Products (78)

78 Results for "antidiabetic agent" in MCE Product Catalog:

12
12 Publications Verification
Cat. No.: HY-15516
CAS No.: 1018899-04-1
Purity:  99.63%
Synonyms: LX-4211; LP-802034
Target:  

SGLT

Research Areas:  

Metabolic Disease

Sotagliflozin (LX-4211) is a potent dual SGLT2/1 inhibitor. Antidiabetic agents.
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-14894
CAS No.: 761423-87-4
Purity:  99.71%
Synonyms: ASP1941
Target:  

SGLT

Research Areas:  

Metabolic Disease

Ipragliflozin (ASP1941) is an orally active and selective SGLT2 inhibitor with IC50s of 7.38 and 1876 nM, 6.73 and 1166 nM, 5.64 and 1380 nM for human SGLT2 and SGLT1, rat SGLT2 and SGLT1, mouse SGLT2 and SGLT1, respectively. Antidiabetic agent .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-14621
CAS No.: 122-48-5
Purity:  99.79%
Synonyms: Vanillylacetone; Gingerone
Zingerone (Vanillylacetone) is a nontoxic methoxyphenol isolated from Zingiber officinale, with potent anti-inflammatory, antidiabetic, antilipolytic, antidiarrhoeic, antispasmodic and anti-tumor properties . Zingerone alleviates oxidative stress and inflammation, down-regulates NF-κB mediated signaling pathways . Zingerone acts as an anti-mitotic agent, and inhibits the growth of neuroblastoma cells . Zingerone can cross the blood-brain barrier (BBB) .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-17638
CAS No.: 666843-10-3
Synonyms: DSP-3235 free base; KGA-3235 free base; GSK-1614235 free base
Target:  

SGLT

Research Areas:  

Metabolic Disease

Mizagliflozin (DSP-3235 free base) is a potent, orally active and selective SGLT1 inhibitor, with a Ki of 27 nM for human SGLT1. Mizagliflozin displays 303-fold selectivity over SGLT2. Mizagliflozin is used as an antidiabetic agent that can modify postprandial blood glucose excursion. Mizagliflozin also exhibits potential in the amelioration of chronic constipation .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B2099A
CAS No.: 1190-53-0
Synonyms: 1-Butylbiguanide hydrochloride
Target:  

AMPK

Research Areas:  

Cancer

Buformin hydrochloride (1-Butylbiguanide hydrochloride), a potent AMPK activator, acts as an orally active biguanide antidiabetic agent. Buformin hydrochloride decreases hepatic gluconeogenesis and lowers blood glucose production in vivo. Buformin hydrochloride also has anti-cancer activities and is applied in cancer study (such as, cervical cancer and breast cancer, et al) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N4103
CAS No.: 17605-67-3
Fucosterol is a sterol isolated from algae, seaweed or diatoms. Fucosterol exhibits various biological activities, including antioxidant, anti-adipogenic, blood cholesterol reducing, anti-diabetic and anti-cancer activities . Fucosterol regulates adipogenesis via inhibition of PPARα and C/EBPα expression and can be used for anti-obesity agents development research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0920
CAS No.: 1156-19-0
Synonyms: U-17835
Target:  

Potassium Channel

Research Areas:  

Metabolic Disease Endocrinology

Tolazamide (U-17835) is an orally active sulfonylurea agent that inhibits sulfonylurea receptor 1 (SUR1) linked to the inwardly rectifying potassium channel (IC50 = 4.2 µM in HEK293 cells transfected with the human receptor). Tolazamide has anti-diabetic properties. Tolazamide can lower blood glucose in sulfonylurea class. Tolazamide decreases insulin dose while continuing to maintain adequate metabolic control. Tolazamide is able to improve or normalize hyperglycemia and HbA .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0254
CAS No.: 29094-61-9
Synonyms: CP 28720; K 4024
Target:  

Potassium Channel

Research Areas:  

Metabolic Disease Cancer

Glipizide (CP 2872; K 4024)?a potent, orally active and sulfonylurea class anti-diabetic agent and can be used for type 2?diabetes mellitus research but not type 1. Glipizide acts by partially blocking ATP-sensitive potassium?(KATP) channels among β cells of pancreatic islets of Langerhans .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B1350A
CAS No.: 751-94-0
Synonyms: Sodium fusidate; SQ-16360
Fusidic acid sodium salt is an orally available antibacterial agent that inhibits bacterial protein synthesis by preventing the release of translation elongation factor G (EF-G) from ribosomes. Fusidic acid sodium salt inhibits the inhibitory and activating effects of interleukins IL-1 and IL-6 on glucose-induced insulin production and exhibits antidiabetic effects in a rat model. Fusidic acid sodium salt improves the symptoms of colitis in rats and inhibits the growth of Toxoplasma gondii and Listeria monocytogenes EGD in vitro, but not in mice .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N2486
CAS No.: 30197-14-9
Desoxyrhaponticin is a kind of oral drug that inhibits effective fatty acid synthesis (FASN), and has a fatal effect on cancer cells. Desoxyrhaponticin has the ability to inhibit glucose uptake, improve oral glucose tolerance as a diabetic agent, and possess anti-diabetic effects.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-125012
CAS No.: 1811510-58-3
Purity:  99.15%
Target:  

MAP4K

Research Areas:  

Metabolic Disease

MAP4K4-IN-3 (Compound 17) is a potent and selective MAP4K4 inhibitor with an IC50 of 14.9 nM in kinase assay, an IC50 of 470 nM in cell assay. Antidiabetic agent .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-130289
CAS No.: 90906-40-4
Synonyms: 4-Hydroxy docosahexaenoic acid; (±)4-HDoHE
Target:  

PPAR

(±)4-HDHA (4-Hydroxy docosahexaenoic acid) is an autoxidation product of Docosahexaenoic acid (HY-B2167) (DHA). (±)4-HDHA is a PPARγ agonist, antidiabetic and anti-inflammatory agent .
loading...
    loading...
Cat. No.: HY-P0058
CAS No.: 151126-32-8
Target:  

Amylin Receptor

Research Areas:  

Metabolic Disease Cancer

Pramlintide is a polypeptide analogue of human amylin. Pramlintide, an antidiabetic agent, is antineoplastic in colorectal cancer .
loading...
    loading...
Cat. No.: HY-P0058B
CAS No.: 187887-46-3
Target:  

Amylin Receptor

Research Areas:  

Metabolic Disease Cancer

Pramlintide acetate is a polypeptide analogue of human amylin. Pramlintide acetate, an antidiabetic agent, is antineoplastic in colorectal cancer .
loading...
    loading...
Cat. No.: HY-W012634
CAS No.: 95-16-9
Benzothiazole is a natural occurring heterocyclic nuclei. Benzothiazole nucleus possesses a number of biological activities such as anticancer, antimicrobial, antidiabetic, anti-inflammatory, antileishmanial, and antiviral. Furthermore, Benzothiazole nucleus can function as an efficacious β-amyloid imaging agent [1][2][3][4].
loading...
    loading...
Cat. No.: HY-109144
CAS No.: 1415472-28-4
Purity:  98.43%
Synonyms: DWP-16001
Target:  

SGLT

Research Areas:  

Metabolic Disease

Enavogliflozin (DWP-16001), an antidiabetic agent, is an orally active, best-in-class and selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor .
loading...
    loading...
Cat. No.: HY-119244
CAS No.: 103213-34-9
Purity:  99.92%
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease

Gly-Pro-pNA hydrochloride is a chromogenic peptide substrate that can be cleaved by the circulating enzyme dipeptidyl peptidase IV (DPP IV). Gly-Pro-pNA hydrochloride is mainly used to detect the activity of aminopeptidases such as DPP IV. Gly-Pro-pNA hydrochloride can be investigated as an experimental antidiabetic agent .
loading...
    loading...
Cat. No.: HY-77490
CAS No.: 6290-03-5
(R)-(-)-1,3-Butanediol is the R-enantiomer of 1,3-Butanediol (HY-77490A). (R)-(-)-1,3-Butanediol exhibits anti-diabetic property in rats. (R)-(-)-1,3-Butanediol can be used as flavoring and fragrance agents. (R)-(-)-1,3-Butanediol is used to regulate the metabolism of carbohydrate and lipid. .
loading...
    loading...
Cat. No.: HY-W075770
CAS No.: 1313-99-1
Synonyms: Nickel monoxide
Nickel(II) oxide (nickel monoxide) is a chemical warfare agent that can enter the body through the respiratory tract and other routes, distributing to organs such as the lungs and testes. The nanoparticle form of nickel(II) oxide (NiO NPs) exhibits antibacterial, anti-leishmanial, anti-diabetic, and anti-cancer activities. NiO NPs can be activated by ultraviolet and visible light, generating reactive oxygen species (ROS). Nickel(II) oxide induces oxidative stress by generating reactive oxygen species, activating the TGF-β1-mediated MAPK and PI3K/AKT pathways, disrupting the MMPs/TIMPs balance, and upregulating the expression of inflammatory factors (IL-1β, IL-6) and apoptosis-related molecules (Bax, caspase-3, p53), while inhibiting the activity of the anti-apoptotic molecule Bcl-2. Nickel(II) oxide induces cytotoxicity, promotes fibrosis, triggers inflammatory responses, and causes apoptosis. Nickel(II) oxide can be applied in research on the safety assessment of nanomaterials, such as in the context of pulmonary fibrosis and reproductive system toxicity .
loading...
    loading...
Cat. No.: HY-163853
CAS No.: 3050509-92-4
Target:  

GLUT Akt

Research Areas:  

Metabolic Disease

Antidiabetic agent 6 (Compound 19) is an antidiabetic Agent. Antidiabetic agent 6 stimulates GLUT4 translocation by activation of the PI3K/AKT-dependent signaling pathway. Antidiabetic agent 6 reduces blood glucose levels in Streptozotocin (HY-13753)-induced diabetic rats .
loading...
    loading...